Tag Archives: American Invents Act

American Invents Act Strategies Highlighted at the IPCC Conference

Saravitz_David-NEW

By David Saravitz, Alston + Bird Day 2 of the 2012 BIO Intellectual Property Counsels’ Committee (IPCC) Spring Conference kicked off with a panel on the America Invents Act (AIA).  The panel focused on how practitioners and the U.S. Patent & Trademark Office (USPTO) are dealing with various provisions of this new patent act. Mr. Ira Finkelstein, Senior Patent Counsel with Baxter Healthcare, led off the session initially discussing the first-inventor-to-file provision of the AIA (§ Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,

BIO IP Counsels Conference Agenda Topics

bio-ip-events-btn

Join us in Austin for BIO’s Intellectual Property Counsels Committee Conference on April 16-18.  Agenda topics are below. The Decline of Process Patents: This session will examine the enforceability of process claims and how it has led to the recent controversy around divided infringement. Unlike claims to machines, manufactures, and compositions, process claims can be divided up by different actors, or by jurisdiction, and conceivably even by time.  Right now the focus is on different Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

BIO Commends Launch of House Patent Reform Process:Expresses concern with inter partes review changes

BIO Commends Launch of House Patent Reform Process Expresses concern with inter partes review changes   Washington, D.C. (March 31, 2011) – Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on the introduction of the America Invents Act, H.R. 1249, in the U.S. House of Representatives: “BIO praises House Judiciary Committee Chairman Lamar Smith (R-TX) for his introduction of a comprehensive patent reform bill similar to the bill adopted by Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , , , , , , , ,